|
National Stock Number(NSN): 6505-00-148-9735 (6505001489735, 001489735)
| NIIN: |
00-148-9735 |
Item Name: |
WARFARIN SODIUM TABLETS |
INC: |
27974
|
| FSC: |
6505
|
Assignment Date: |
|
CRIT: |
|
IIG: |
27974 |
| ISC: |
2 |
Date Standardized: |
|
HMIC: |
|
DODIC: |
|
| NSC: |
4 |
Cancellation Date: |
Apr-01-1995 |
PMIC: |
A |
FIIG: |
A510N0 |
| ESD: |
|
Schedule B: |
|
DEMIL: |
E |
DEMIL INT: |
|
| TIIC: |
4 |
Originator: |
|
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
COUMADIN |
04490
|
BRISTOL-MYERS SQUIBB PHARMA COMPANY |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
COUMADIN TABLETS |
04490
|
BRISTOL-MYERS SQUIBB PHARMA COMPANY |
H |
5 |
1 |
|
|
|
|
|
|
|
|
|
NDC00056-0170-75 |
04490
|
BRISTOL-MYERS SQUIBB PHARMA COMPANY |
H |
3 |
2 |
|
|
|
|
|
|
|
|
|
NDC0056-0170-75 |
04490
|
BRISTOL-MYERS SQUIBB PHARMA COMPANY |
H |
3 |
2 |
|
|
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
JDC |
L |
|
Q |
|
A |
|
$48.65 |
BX |
|
C2201X- |
|
H |
| DF |
JDC |
L |
|
Q |
|
A |
|
$10.29 |
BX |
|
------N |
|
H |
| DM |
JDC |
L |
Z |
Q |
|
A |
|
$48.65 |
BX |
|
13M4--1 |
|
H |
| DN |
JDC |
L |
|
Q |
|
A |
|
$48.65 |
BX |
|
9L----- |
|
H |
| DS |
JDC |
L |
|
Q |
|
A |
|
$48.65 |
BX |
|
------- |
|
H |
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
2.000 MILLIGRAMS WARFARIN SODIUM ACTIVE INGREDIENT |
| CBBL |
FEATURES PROVIDED |
INDIVIDUALLY SEALED |
| CQCT |
PRIMARY CONTAINER TYPE |
STRIP |
| ECWT |
EXTERIOR CONTAINER WEIGHT |
23.00 POUNDS |
| EXME |
EXTERIOR CONTAINER CUBIC MEASURE |
2.10 CUBIC FEET |
| EXQT |
EXTERIOR CONTAINER QUANTITY |
100 |
| FEAT |
SPECIAL FEATURES |
100 TABLETS PER PACKAGE |
| PKQT |
INTERMEDIATE PACKAGE QUANTITY |
10 |
| PKTY |
UNIT PACKAGE TYPE |
PACKAGE |
| SUCB |
UNIT OF ISSUE CUBE |
0.021 CUBIC FEET |
| SUWT |
UNIT OF ISSUE WEIGHT |
0.22 POUNDS |
| THPE |
THERAPEUTIC EQUIVALENT |
COUMADIN BY DUPONT |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| A111 |
|
|
3 |
Z |
|
|
|
|
| FSKX |
|
|
3 |
Z |
|
|
|
|
| MC15 |
|
|
3 |
Z |
|
|
|
|
| N9LM |
|
|
3 |
Z |
|
|
|
|
| YK01 |
|
|
|
|
|
|
YK |
YK |
|